000 01181 a2200313 4500
005 20250517194630.0
264 0 _c20181126
008 201811s 0 0 eng d
022 _a1879-1891
024 7 _a10.1016/j.ajo.2017.12.009
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aOli, Avadhesh
245 0 0 _aPreoperative Bevacizumab Administration in Proliferative Diabetic Retinopathy Patients Undergoing Vitrectomy: A Randomized and Controlled Trial Comparing Interval Variation.
_h[electronic resource]
260 _bAmerican journal of ophthalmology
_c03 2018
300 _a168-169 p.
_bdigital
500 _aPublication Type: Letter; Comment
650 0 4 _aAngiogenesis Inhibitors
650 0 4 _aAntibodies, Monoclonal
650 0 4 _aBevacizumab
650 0 4 _aDiabetic Retinopathy
650 0 4 _aHumans
650 0 4 _aVascular Endothelial Growth Factor A
650 0 4 _aVitrectomy
650 0 4 _aVitreous Hemorrhage
700 1 _aBalakrishnan, Divya
700 1 _aRani, Padmaja Kumari
773 0 _tAmerican journal of ophthalmology
_gvol. 187
_gp. 168-169
856 4 0 _uhttps://doi.org/10.1016/j.ajo.2017.12.009
_zAvailable from publisher's website
999 _c27984672
_d27984672